Moneycontrol Be a Pro
Get App
Last Updated : Jun 13, 2017 11:24 AM IST | Source:

Sun Pharmaceutical gains 3% on USFDA approval for Zetia tablets

The tablet Zetia is used to lower cholesterol in the blood.

Shares of Sun Pharmaceutical Industries advanced 3.4 percent intraday Tuesday on the back of USFDA approval for generic Zetia tablets.

The company’s wholly owned subsidiaries has received final approval from United States Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for generic version of Zetia, (ezetimibe) tablets 10mg.

The tablet Zetia is used to lower cholesterol in the blood.


These generic ezetimibe tablets are therapeutic equivalents of Merck’s Zetia tablets.

According to IMS data, ezetimibe tablets had annual sales of approximately USD 2.7 billion in the US for the 12 months ended April 2017.

At 09:26 hrs Sun Pharmaceutical Industries was quoting at Rs 546.35, up Rs 13.20, or 2.48 percent on the BSE.

Posted by Rakesh Patil

The Great Diwali Discount!
Unlock 75% more savings this festive season. Get Moneycontrol Pro for a year for Rs 289 only.
Coupon code: DIWALI. Offer valid till 10th November, 2019 .
First Published on Jun 13, 2017 09:30 am
Follow us on
Available On
PCI DSS Compliant